TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Cryogenetics AS
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
3,637
|
2,962
|
2,855 |
| Financial expenses |
96
|
89
|
75 |
| Earnings before taxes |
763
|
348
|
370 |
| Total assets |
4,643
|
4,192
|
3,681 |
| Current assets |
2,337
|
2,222
|
2,131 |
| Current liabilities |
778
|
915
|
731 |
| Equity capital |
2,846
|
2,283
|
1,984 |
| - share capital |
394
|
421
|
444 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
61.3%
|
54.5%
|
53.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
21.0%
|
11.7%
|
13.0% |
| Return on assets (ROA) |
18.5%
|
10.4%
|
12.1% |
| Current ratio |
300.4%
|
242.8%
|
291.5% |
| Return on equity (ROE) |
26.8%
|
15.2%
|
18.6% |
| Change turnover |
864
|
256
|
504 |
| Change turnover % |
31%
|
9%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.